Cancer cells with persistent NRF2 activation adapt their metabolism by exploiting the glutamine transporter SLC1A5 for glutamine uptake and glutaminase for its conversion to glutamate (Romero et al, 2017; Sayin et al, 2017). This evidence concerns the gene NFE2L2 and cancer.